Hazlett, Burt & Watson’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$653K Buy
5,440
+25
+0.5% +$2.89K 0.2% 115
2025
Q4
$572K Buy
5,415
+21
+0.4% +$1.97K 0.18% 122
2025
Q3
$453K Sell
5,394
-214
-4% -$17.6K 0.16% 133
2025
Q2
$446K Buy
5,608
+1,392
+33% +$111K 0.18% 117
2025
Q1
$381K Sell
4,216
-340
-7% -$31.7K 0.17% 125
2024
Q4
$451K Sell
4,556
-572
-11% -$59K 0.2% 107
2024
Q3
$586K Buy
5,128
+276
+6% +$32.8K 0.27% 80
2024
Q2
$601K Buy
4,852
+701
+17% +$90.3K 0.31% 71
2024
Q1
$547K Buy
4,151
+140
+3% +$17.3K 0.33% 63
2023
Q4
$437K Buy
4,011
+110
+3% +$11.4K 0.29% 69
2023
Q3
$403K Sell
3,901
-10
-0.3% -$1.08K 0.3% 70
2023
Q2
$454K Buy
3,911
+44
+1% +$5K 0.34% 60
2023
Q1
$410K Buy
3,867
+238
+7% +$25.7K 0.34% 62
2022
Q4
$402K Sell
3,629
-12
-0.3% -$1.23K 0.35% 55
2022
Q3
$313K Buy
3,641
+556
+18% +$49.6K 0.3% 69
2022
Q2
$282K Buy
3,085
+387
+14% +$34.3K 0.26% 83
2022
Q1
$221K Buy
+2,698
New +$213K 0.18% 119

Other funds holding MRK

Hazlett, Burt & Watson's MRK Position: Q1 2026 in Review

Hazlett, Burt & Watson increased its Merck (MRK) stake by 0.46% in Q1 2026, buying an estimated $2.89K and bringing the position to 5,440 shares worth $653K. The position accounts for 0.2% of the portfolio, ranked #115.

Hazlett, Burt & Watson first reported a position in MRK in Q1 2022 and has held it in 17 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Hazlett, Burt & Watson held 5,440 shares of Merck worth $653K as of Q1 2026.
  • Hazlett, Burt & Watson bought 25 Merck shares in Q1 2026, an estimated $2.89K.
  • Merck made up 0.2% of Hazlett, Burt & Watson's portfolio in Q1 2026, its #115 holding.
  • Hazlett, Burt & Watson first reported a position in Merck in Q1 2022 and has held it in 17 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2026, filed 14 May 2026.